Fill volume variability in ophthalmic/otic manufacturing: batch disposition and patient risk assessment



Published on 31/12/2025

Understanding Fill Volume Variability in Ophthalmic and Otic Manufacturing: An Investigation Approach

Fill volume variability in ophthalmic and otic manufacturing can pose serious risks to both batch disposition and end-user safety. As professionals in pharmaceutical manufacturing, quality control, and regulatory affairs, understanding the potential causes and developing an effective investigation framework is critical. This article outlines a structured approach for investigating fill volume variability incidents, enabling you to comprehensively assess and address potential issues.

By following the detailed workflow discussed here, you will be equipped to identify symptoms, evaluate root causes, implement corrective actions, and enhance overall compliance with Good Manufacturing Practices (GMP).

Symptoms/Signals on the Floor or in the Lab

The first step in addressing fill volume variability is understanding the symptoms or signals indicating a problem. Common signs of fill volume issues include:

  • Consistent underfilling or overfilling: Measurements from multiple batches show that fill volumes deviate from the established specifications.
  • Increased customer complaints: Reports of product inadequacy or nonconformance from healthcare professionals or end-users.
  • High out-of-specification (OOS) results: Quality
control testing reveals deviations during batch release processes.
  • Quality defect trends: An upward trend in defects noted in batch records or production logs, which indicate a recurring problem.
  • Operational machine alarms: Automated systems trigger alarms related to volumetric capacity or fill accuracy during production processes.
  • Understanding these signs allows for timely identification of potential concerns and initiates the need for a structured investigation.

    Likely Causes

    To investigate fill volume variability effectively, it is crucial to categorize potential root causes into six key areas: Materials, Method, Machine, Man, Measurement, and Environment.

    Category Potential Causes
    Materials Variation in raw material properties, such as density or viscosity.
    Method
    • Inconsistent procedures for fill volume calibration.
    • Changes to standard operating procedures (SOPs) not implemented correctly.
    Machine
    • Incorrect machine settings.
    • Wear and tear on filling equipment leading to performance degradation.
    Man Operator errors during the filling process or inadequate training.
    Measurement Calibration errors in volumetric measurement instruments.
    Environment Temperature or humidity fluctuations affecting material properties.

    Understanding the multifactorial nature of fill volume variability aids in developing a holistic perspective during the investigation.

    Immediate Containment Actions (First 60 Minutes)

    The initial response to fill volume variability is critical for mitigating potential risks. Within the first 60 minutes, the following containment actions should be undertaken:

    • Cease Production: Stop any ongoing manufacturing processes to prevent further defects.
    • Assess the Scale of the Issue: Collect data on the number of affected batches and their production timelines.
    • Isolate Affected Batches: Quarantine affected products to prevent them from reaching the market.
    • Gather Initial Evidence: Document observations, machine statuses, fill volume measurements, and personnel accounts during the filling process.
    • Notify Relevant Teams: Bring in stakeholders including quality assurance, production, and regulatory representatives for immediate assessment.

    Taking actionable containment steps early can limit potential risks to patient safety and enhance regulatory compliance.

    Investigation Workflow

    A structured investigation workflow enhances the accuracy and thoroughness of the root cause analysis. The key phases include:

    1. Data Collection: Collect comprehensive data on affected batches, surrounding manufacturing conditions, and contextual information such as operator shift changes.
    2. Data Validation: Ensure the collected data is accurate, complete, and representative of all processes involved. Verify through cross-referencing documentation against records.
    3. Initial Assessment: Conduct a preliminary review of the data to identify any glaring inconsistencies or anomalies that signal specific areas for deeper investigation.
    4. Root Cause Identification: Utilize root cause analysis tools, such as 5-Why and Fishbone diagrams, to systematically explore contributing factors.
    5. Documentation: Maintain detailed records of all findings, discussions, and analyses to ensure audit readiness and compliance.

    The effectiveness of this workflow is augmented by collaboration across departments, ensuring a multidisciplinary approach to problem-solving.

    Root Cause Tools

    Employing appropriate root cause analysis tools can streamline the identification process. The following tools are widely used:

    • 5-Why Analysis: This tool prompts users to ask “why” repeatedly (typically five times) until root causes are revealed. Use this for straightforward issues with defined symptoms.
    • Fishbone Diagram (Ishikawa): This visual tool categorizes potential causes into structured categories (Materials, Method, Machine, etc.) and is effective for complex issues with multiple performing factors.
    • Fault Tree Analysis: Root causes are delineated in a logical diagram format. Use this for analyzing interactions among failures and their effects on the system, ideal for machine-driven issues.

    Choose the appropriate tool based on the complexity of the problem and the clarity of the symptoms.

    CAPA Strategy

    Corrective and Preventive Actions (CAPA) play a pivotal role in managing fill volume variability incidents. An effective CAPA strategy includes:

    • Correction: Take immediate steps to rectify identified issues, such as recalibrating machines or retraining personnel on filling procedures.
    • Corrective Action: Implement modifications to processes or systems to prevent recurrence, which may involve revising SOPs or maintenance schedules for machinery.
    • Preventive Action: Ensure the establishment of ongoing monitoring mechanisms to evaluate production reliability, such as periodic review of calibration techniques and training refreshers for staff.

    Document all CAPA actions meticulously in your quality management system to support future compliance audits and regulatory inspections.

    Control Strategy & Monitoring

    Monitoring is a crucial aspect of managing fill volume variability. A robust control strategy includes:

    • Statistical Process Control (SPC): Use SPC tools to analyze production data trends in real-time, allowing for deviations from historical averages to be quickly identified.
    • Regular Sampling: Conduct regular sampling and testing of fill volumes to catch deviations before products reach consumers.
    • Alarm Systems: Implement automated alarm systems that flag anomalies during production to enable timely intervention.
    • Verification Protocols: Establish verification procedures to ensure that any equipment interventions result in expected fill volume outcomes.

    An effective control strategy enhances compliance with GMP standards and reduces risks associated with fill volume variability.

    Related Reads

    Validation / Re-qualification / Change Control Impact

    Investigations into fill volume variability may necessitate a review of validation procedures, re-qualification of affected manufacturing processes, and updates to change control documentation, particularly when:

    • Equipment modifications were performed to address the root cause.
    • Significant procedural changes were implemented to rectify identified issues.
    • The introduction of new materials or manufacturing processes has occurred.

    Each of these scenarios requires thorough assessment and documentation to ensure continued compliance with regulatory requirements.

    Inspection Readiness: What Evidence to Show

    To demonstrate compliance during regulatory inspections (FDA, EMA, MHRA), you should be prepared with relevant evidence, including:

    • Records: Provide a complete set of records related to the affected batches, including batch production records (BPRs) and quality control records.
    • Logs: Maintain detailed operational logs documenting production conditions and any significant process changes.
    • Deviation Reports: Ensure all deviation reports generated during the investigation process are readily available.
    • CAPA Documentation: Keep a record of all CAPA actions taken, including any evidence collected or actions implemented to prevent future incidents.

    Being prepared with comprehensive documentation will facilitate smoother interactions with regulatory bodies and enhance your inspection readiness.

    FAQs

    What constitutes fill volume variability?

    Fill volume variability refers to deviations from the specified fill volume of products, such as ophthalmic and otic solutions, which can occur during the manufacturing process.

    How is fill volume variability detected?

    Fill volume variability can be detected through regular quality control testing, customer complaints, operational alarms, and monitoring systems.

    What are the regulatory implications of fill volume variability?

    Regulatory implications include potential non-compliance with GMP standards, leading to possible enforcement actions from governing bodies like the FDA or EMA.

    How can we prevent fill volume variability?

    Preventive measures include regular equipment calibration, strict adherence to SOPs, employee training, and robust monitoring systems.

    What is the role of CAPA in addressing variability?

    CAPA is crucial for corrections and improvements to mitigate risks associated with fill volume variability, ensuring compliance and product quality.

    What root cause analysis tools should be used?

    Root cause tools like 5-Why, Fishbone Diagrams, and Fault Tree Analysis can be used depending on the complexity of the issue being investigated.

    How do we ensure ongoing compliance after an incident?

    Ongoing compliance can be ensured through continuous training, regular equipment maintenance, process reviews, and effective monitoring strategies.

    How do we prepare for inspections related to fill volume issues?

    Preparation involves gathering relevant documentation, including batch records, deviation reports, CAPA documentation, and evidence of corrective actions taken.

    What should be included in a deviation report?

    A deviation report should include a description of the deviation, root cause analysis data, corrective actions taken, and a review of the impact on product quality.

    When should we update SOPs related to fill volume processes?

    SOPs should be updated when there are significant changes in processes, recurring deviations are identified, or as part of CAPA actions.

    Is it necessary to conduct a risk assessment for variability incidents?

    Yes, conducting a risk assessment is important to evaluate the potential impact on product quality and patient safety, guiding corrective actions effectively.

    What documentation is needed to maintain inspection readiness?

    Necessary documentation includes batch production records, QC testing results, logs of processes, deviation reports, and CAPA actions.

    Pharma Tip:  CCIT failure during inspection readiness: batch disposition and patient risk assessment